The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 10.10
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Technology Venture Capital Funds Suffer Value Drop

Wed, 19th Oct 2016 11:05

LONDON (Alliance News) - Oxford Technology Management reported Wednesday a reduction in net asset value across all four of its London-listed venture capital funds in the first half of their financial years.

Oxford Technology VCT PLC reported its NAV per share reduced to 59.7 pence from 61.2p in the six months to August 31, as the fund's net assets dropped to GBP3.2 million at the end of the period, down from GBP3.3 million at February 29.

The fund reported a total NAV return per share of 113.7p in the six month period. The share price of the fund slipped to 38.0p at August 31 from 40.5p at February 29.

Shares in Oxford Technology VCT were untraded at 42.87p Wednesday.

Chairman Alex Starling noted over 85% of Oxford Technology VCT's net asset value is bound up in holdings in private company Select Technology Ltd and AIM-listed biotechnology company Scancell Holdings PLC. Starling said recent changes to qualification conditions for being a venture capital trust will not be an issue for the fund as it is not looking to invest in any new companies.

Oxford Technology 2 VCT PLC reported its NAV per share dipped to 28.0p from 28.2p over the six months to August 31, with net assets broadly flat at GBP1.9 million.

Total NAV return per share in the fund was 41.0p. The share price of Oxford Technology 2 rose to 22.0p at August 31 from 20.0p at February 29.

Shares in Oxford Technology VCT 2 were untraded at 18.43p Wednesday.

Oxford Technology VCT 3 PLC's NAV per share fell to 87.3p from 101.6p over the six months to August 31, as net assets declined to GBP5.9 million from GBP6.9 million.

The fund produced a total NAV return per share for the period of 119.3p. The share price of Oxford Technology 3 fell to 57.5p at August 31 from 62.5p at February 29.

Shares in Oxford Technology VCT 3 were untraded at 50.00p Wednesday.

Oxford Technology VCT 4 PLC reported its NAV per share declined slightly to 66.5p from 66.8p over the six months to August 31, with net assets broadly flat at GBP7.7 million. The fund's total NAV return per share for the period was 103.5p. The share price of Oxford Technology 4 fell to 47.0p at August 31 from 52.0p at February 29.

Shares in Oxford Technology VCT 4 were untraded at 45.0p Wednesday.

Oxford Technology VCT 4 Chairman David Livesley noted minor rises in the value of some of the fund's portfolio companies had been more than offset by a fall in the share price of Castleton Technology PLC over the period.

By Adam Clark; adamclark@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
22 Oct 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Oct 2021 20:41

IN BRIEF: Scancell bases new facility at Oxford Science Park

IN BRIEF: Scancell bases new facility at Oxford Science Park

Read more
5 Oct 2021 22:03

IN BRIEF: Scancell doses first subject in Covidity phase one trial

IN BRIEF: Scancell doses first subject in Covidity phase one trial

Read more
26 Aug 2021 12:53

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

Read more
26 Aug 2021 12:38

Scancell gets MHRA approval for Modi-1 clinical trial

(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.

Read more
17 Aug 2021 15:32

Scancell chooses needle-free tech for Covid vaccine candidates

(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.

Read more
30 Jul 2021 14:24

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

Read more
29 Jul 2021 22:08

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

Read more
28 Jul 2021 22:00

IN BRIEF: Scancell turns once again to Durrant to lead company

IN BRIEF: Scancell turns once again to Durrant to lead company

Read more
22 Jun 2021 15:21

Scancell makes progress with 'Covidity' trial plans

(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.

Read more
22 Jun 2021 12:14

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

Read more
7 Jun 2021 13:58

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

Read more
7 Jun 2021 10:38

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

Read more
30 Apr 2021 14:30

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

Read more
19 Feb 2021 20:13

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.